Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoding Xu

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 13, 2025
m<sup>6</sup>A-Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate MetabolismJuanyi Shi, Sintim Mui, Yongcong Yan, et al.
Experimental Hematology & Oncology|January 8, 2026
PRL-3 up-regulates exosomal ITGαvβ5 expression to promote liver pre-metastatic niche formation and colon cancer liver metastasisQiusheng Lan, Heyang Xu, Yujie Zeng, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 20, 2018
Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer TherapyXiaoding Xu, Jun Wu, Shuaishuai Liu, et al.
Ebiomedicine|February 13, 2025
TCL1A in naïve B cells as a therapeutic target for type 1 diabetesSiweier Luo, Lina Zhang, Chunfang Wei, et al.
ACS Nano|February 7, 2018
Intracellular Mechanistic Understanding of 2D MoS<sub>2</sub> Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer TherapyXianbing Zhu, Xiaoyuan Ji, Na Kong, et al.
Nano Letters|June 2, 2020
Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer TherapyYujing Li, Jianxun Ding, Xiaoding Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 7, 2026
SIRT5-RAC2 Axis Drives Monocyte-to-Macrophage Differentiation to Promote Inflammatory Injury in Premature Ovarian InsufficiencyWenjing TanTai, Yaqi Li, Shengnan Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 1, 2020
Nanoparticles (NPs)-Meditated LncRNA AFAP1-AS1 Silencing to Block Wnt/<i>β</i>-Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer RadiotherapyZhuofei Bi, Qingjian Li, Xiaoxiao Dinglin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2019
Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition TherapyYan Nie, Hongyan Huang, Mingyan Guo, et al.
Cell Reports|June 11, 2020
Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR CascadeXiaorong Lin, Xiaoxiao Dinglin, Siting Cao, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 13, 2025
m<sup>6</sup>A-Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate MetabolismJuanyi Shi, Sintim Mui, Yongcong Yan, et al.
Experimental Hematology & Oncology|January 8, 2026
PRL-3 up-regulates exosomal ITGαvβ5 expression to promote liver pre-metastatic niche formation and colon cancer liver metastasisQiusheng Lan, Heyang Xu, Yujie Zeng, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 20, 2018
Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer TherapyXiaoding Xu, Jun Wu, Shuaishuai Liu, et al.
Ebiomedicine|February 13, 2025
TCL1A in naïve B cells as a therapeutic target for type 1 diabetesSiweier Luo, Lina Zhang, Chunfang Wei, et al.
ACS Nano|February 7, 2018
Intracellular Mechanistic Understanding of 2D MoS<sub>2</sub> Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer TherapyXianbing Zhu, Xiaoyuan Ji, Na Kong, et al.
Nano Letters|June 2, 2020
Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer TherapyYujing Li, Jianxun Ding, Xiaoding Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 7, 2026
SIRT5-RAC2 Axis Drives Monocyte-to-Macrophage Differentiation to Promote Inflammatory Injury in Premature Ovarian InsufficiencyWenjing TanTai, Yaqi Li, Shengnan Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 1, 2020
Nanoparticles (NPs)-Meditated LncRNA AFAP1-AS1 Silencing to Block Wnt/<i>β</i>-Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer RadiotherapyZhuofei Bi, Qingjian Li, Xiaoxiao Dinglin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2019
Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition TherapyYan Nie, Hongyan Huang, Mingyan Guo, et al.
Cell Reports|June 11, 2020
Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR CascadeXiaorong Lin, Xiaoxiao Dinglin, Siting Cao, et al.
Pageof 10